New York Life Investment Management »

Summit Therapeutics shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $228k 11k 20.66
2025-06-30 $241k 11k 21.28
2025-03-31 $223k 12k 19.29
2024-12-31 $201k 11k 17.85

More positions owned by New York Life Investment Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
New York Life Invts Active E Nyli Mackay Core (CPLB)
New York Life Investments Et Candriam Us Lrg (IQSU)
Meta Platforms Cl A (META)
Broadcom (AVGO)
New York Life Investments Et Candriam Us Mid (IQSM)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Vanguard World Mega Cap Index (MGC)
New York Life Investments Et Nyli Candriam In (IQSI)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Fltg Rate Nt Etf (FLOT)

View all positions for New York Life Investment Management

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
State Street Corporation
Geode Capital Management
Susquehanna International
Pictet Asset Management Holding SA
Citadel Advisors
UBS Group
Apeiron Capital
Nomura Holdings
Standard Life Aberdeen
Squarepoint Ops
Sofinnova Ventures

View all funds holding Summit Therapeutics